Disney shareholders rejected an investor proposal to withdraw participation in the Human Rights Campaign's corporate equity index, which rates workplaces on lesbian, gay, bisexual, transgender and queer equality.
The company booked a net income of $5 million for Q4 FY24 despite rising processing and warehousing expenses and lower HRC steel prices. The sales volume grew by 13%, and I think it could continue to improve in FY25. However, I think that HRC steel prices could stabilize at around $600/t over the coming months as China's economic recovery is still sluggish.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| JM John Malone Amundi | 134,960 | $15.33M | $21.05M | $5.72M | 37.3% |
| Electronic Equipment, Instruments & Components Industry | Information Technology Sector | John Groetelaars CEO | NYSE Exchange | 431475102 CUSIP |
| US Country | 10,000 Employees | 14 Dec 2021 Last Dividend | 2 Mar 1992 Last Split | - IPO Date |
Hill-Rom Holdings, Inc. is a prominent global entity that specializes in medical technology, organized into three key operational sectors: Patient Support Systems, Front Line Care, and Surgical Solutions. Established in 1969, the company is headquartered in Chicago, Illinois, and provides a comprehensive range of products and services that cater to various healthcare settings, from acute care facilities to individual home care needs. Through its dedicated sales force and distribution partnerships, Hill-Rom delivers innovative solutions that support medical professionals in enhancing patient care and operational efficiency.
This division offers essential medical equipment including medical-surgical beds, intensive care unit beds, and bariatric patient beds. Additionally, it provides patient lifts and other related devices, non-invasive therapeutic surfaces, and software solutions designed to improve patient management. Service contracts for capital equipment are also available, ensuring that healthcare providers maintain optimal functionality of their tools.
The Front Line Care segment supplies comprehensive patient monitoring and diagnostic instruments. Their offerings include a range of general patient examination tools, continuous monitoring systems, diagnostic cardiology products, and vision screening devices. Moreover, it features a suite of respiratory health products designed to address airway blockages, such as the Vest System, VitalCough System, MetaNeb System, Monarch, and Life2000, thereby enhancing patient recovery and care.
This segment focuses on equipping operating rooms with critical infrastructure, which includes cutting-edge surgical tables, specialized lighting, and ceiling-mounted pendants that facilitate surgical procedures. Furthermore, the division manufactures precision positioning devices designed for various types of surgeries, including shoulder, hip, spinal, and lithotomy procedures. The inclusion of universal positioning accessories ensures compatibility with a wide range of operating room tables, thereby enhancing surgical workflow.
Hill-Rom's products and services are distributed directly to acute and extended care facilities through a dedicated sales force, as well as via distributors. The company also offers direct sales and rentals to individual patients for home use, in addition to providing supplies to primary care facilities through distribution partners. This broad distribution strategy allows Hill-Rom to cater to a wide array of healthcare providers and settings.
The comprehensive clinical solutions offered by Hill-Rom are designed to support not only acute and primary care but also clinical research organizations. This extensive service range ensures that the needs of various healthcare environments are met, thereby promoting effective patient management and care outcomes.